Successful T cell engineering with gene scissors
The idea of genetically modifying a patient’s own immune cells and deploying them against infections and tumors has been around since the 1980s. But to this day modified T cells are still not as effective as natural T cells and have been only been of limited clinical value. Using the new CRISPR-Cas9 gene editing tool, a team at the Technical University of Munich (TUM) has now engineered T cells that are very similar to physiological immune cells.
There are two forms of T cell therapy: either a recipient receives cells from a donor, or the recipient’s own T cells are removed, genetically reprogrammed in a laboratory and unleashed against an infection or tumor in the body. While the first method has proven to be successful in clinical models, reprogramming T cells is still beset with problems.
The team led by Professor Dirk Busch, Director of the Institute for Medical Microbiology, Immunology and Hygiene at the TUM, has generated modified T cells for the first time that are very similar to their natural counterparts and could solve some of those problems. To do so, they utilized the new CRISPR-Cas9 gene scissors, which can be used to snip out and replace targeted segments of the genome.
Both the conventional methods and the new method target the key homing instrument of T cells, known as the T cell receptor. The receptor, residing on the cell’s surface, recognizes specific antigens associated with pathogens or tumor cells, which the T cell is then able to attack. Each receptor is made up of two molecular chains that are linked together. The genetic information for the chains can be genetically modified to produce new receptors that are able to recognize any desired antigen. In this way, it is possible to reprogram T cells.
Targeted exchange using the CRISPR-Cas9 gene scissors
The problem with conventional methods is that the genetic information for the new receptors is randomly inserted into the genome. This means that T cells are produced with both new and old receptors or with receptors having one old and one new chain. As a result, the cells do not function as effectively as physiological T cells and are also controlled differently. Moreover, there is a danger that the mixed chains could trigger dangerous side effects (Graft-versus-Host Disease, GvHD).
“Using the CRISPR method, we’ve been able to completely replace the natural receptors with new ones, because we’re able to insert them into the very same location in the genome. In addition, we’ve replaced the information for both chains so that there are no longer any mixed receptors,” explains Kilian Schober, who is a lead author of the new study along with his colleague Thomas Müller.
Thomas Müller explains the advantages of the modified T cells: “They’re much more similar to physiological T cells, yet they can be changed flexibly. They’re controlled like physiological cells and have the same structure, but are capable of being genetically modified.“ The scientists have demonstrated in a cell culture model that T cells modified in this way behave nearly exactly like their natural counterparts.
“Another advantage is that the new method allows multiple T cells to be modified simultaneously so that they’re able to recognize different targets and can be used in combination. This is especially interesting for cancer therapy, because tumors are highly heterogeneous,” Dirk Busch adds. In the future, the team plans to investigate the new cells and their properties in preclinical mouse models, an important step in preparing for clinical trials with humans.
Learn more: Successful T cell engineering with gene scissors
The Latest on: CRISPR-Cas9 gene scissors
via Google News
The Latest on: CRISPR-Cas9 gene scissors
- 3 Reasons to Go Long Crispr Therapeuticson June 22, 2020 at 9:12 am
Levered to the groundbreaking gene-editing industry, CRSP stock deserves extra attention for anyone interested in phenomenal gains. Source: Catalin Rusnac/ShutterStock.com It’s amazing to think how ...
- Does gene editing hold key to better healthcare?on June 22, 2020 at 4:41 am
Simply put, it is like using a pair of scissors to cut off unwanted ... system could thwart some efforts to develop gene therapies based on CRISPR-Cas9, according to a 2018 study.
- Alexander Says Gene Editing Technology, When Used Properly, Has The Potential To Transform Human Healthon June 18, 2020 at 5:00 pm
Senate health committee Chairman Lamar Alexander on Tuesday said that “gene editing technology, like CRISPR-cas9, has the potential to transform human health ... to act as scissors to cut ...
- Using light to speed up CRISPR-Cas9 gene editingon June 12, 2020 at 7:22 am
A team of researchers at Johns Hopkins University has developed a way to speed up the CRISPR-Cas9 gene-editing process by using light-sensitive nucleotides. In their paper published in the journal ...
- Conditional expression of PfAP2-G for controlled massive sexual conversion in Plasmodium falciparumon June 10, 2020 at 11:12 am
In asexual parasites, the pfap2-g gene is epigenetically silenced by heterochromatin ... i.e., between the promoter and the coding sequence] using the CRISPR-Cas9 system (20). The construct consisted ...
- Directed protein evolution with CRISPR-Cas9on May 26, 2020 at 10:25 am
Using the CRISPR-Cas9 gene scissors, the researchers are able to cut at specific sites at the gene of the inserted protein. By adding specially made building blocks, planned errors occurring ...
- Gene editing ‘vital’ for future of UK farmingon May 26, 2020 at 6:41 am
See also: Biotech crops can help mitigate climate change, say experts Gene-editing techniques – such as Crispr-Cas9 – enable genes to be changed using “molecular scissors” to replace one ...
via Bing News